What is PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019?

PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 is Malaysia P.U. (A), cited as P.U. (A) 207 2019, currently marked in force and first recorded in 2019.

Is PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 still in force?

Yes — PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 is currently in force.

When did PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 take effect?

PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 was first recorded in 2019.

How many sections does PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 have?

PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 contains 3 sections.

Where can I read the official version of PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019?

The official text of PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 is published at lom.agc.gov.my.

PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019 (No. 207)

Seksyen 1

Perintah ini bolehlah dinamakan Perintah Racun (Pindaan Senarai Racun) (No. 3) 2019.

Pindaan Jadual Pertama 2.

Akta Racun 1952 dipinda dalam Jadual Pertama—

(a)

dalam Senarai Racun—

(i)

dengan menggantikan butiran

“Adenosine”

dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

P.U. (A) 207 3

Names

Exempt

Group A

Group B

Group C

Group D

“Adenosine

-

Medicinal preparations unless exempted

All preparations unless in

Group C or exempted

-

Adenosine in—

(1)

raw cordyceps

(2)

product which is registered under the

Control of Drugs and

Cosmetics Regulations 1984 containing adenosine from natural resources

(3)

cosmetic which is notified under the

Control of Drugs and

Cosmetics Regulations 1984

(4)

food”;

P.U. (A) 207 4

(ii)

dengan menggantikan butiran “N- [(1S) - 1-

(Aminocarbonyl) - 2- methylpropyl] - 1-

(cyclohexylmethyl)

1H-indazole- 3- carboxamide (AB-CHMINACA)” dengan butiran “N-[(2S)-1-Amino-3-methyl-1-oxobutan-2yl]-1-

(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) (DD)”;

(iii)

dengan memasukkan selepas butiran “2-Amino-1-(2, 5-dimethoxy-4- methyl) phenylpropane (DD)” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“N-[(2S)-1-Amino-3-

methyl-1-oxobutan-2-yl]-

1-pentyl- 1H-indazole-3-

carboxamide

(AB-PINACA) (DD)

-

All preparations”;

P.U. (A) 207 5

(iv)

dengan menggantikan butiran

“Ammonia”

dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Ammonia

-

5% and above

(1)

Below 5%

(2)

Ammonia inside cooling units of a refrigerator, air conditioner and smelling bottles

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 6

(v)

dengan memasukkan selepas butiran “Apraclonidine; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Apremilast

-

All preparations”;

(vi)

dengan menggantikan butiran “Azelaic Acid” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Azelaic Acid

-

All medicinal preparations unless in

Group C

Medicinal preparations for external use

All preparations unless in

Group B or Group C”;

P.U. (A) 207 7

(vii)

dengan menggantikan butiran “Bismuth; its salts” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Bismuth;

its salts

-

All medicinal preparations unless in Group C or exempted

Suppositories and medicinal preparations for external use unless exempted

All preparations unless in

Group B,

Group C or exempted

-

Cosmetics including those for the eye, containing bismuth oxychloride as a pearling or colouring agent”;

(viii)

dengan menggantikan butiran

“Caffeine”

dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Caffeine

-

All preparations unless exempted

(1)

Caffeine in—

P.U. (A) 207 8

(i)

food or beverages

(ii)

cosmetic which is notified under the Control of Drugs and

Cosmetics Regulations 1984

(iii)

product which is registered under the Control of Drugs and

Cosmetics Regulations 1984

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(ix)

dengan memotong butiran “Carfentanil citrate” dan butir-butir yang berhubungan dengannya;

(x)

dengan menggantikan butiran “Chloroform” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

P.U. (A) 207 9

Names

Exempt

Group A

Group B

Group C

Group D

“Chloroform Veterinary preparations for food-producing animals

-

Medicinal preparation unless in

Group A or exempted

All preparation unless in

Group A,

Group C or exempted

-

Strengths under 10% unless

Group A”;

(xi)

dengan menggantikan butiran “Creosote, obtained from wood” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Creosote, obtained from wood

-

Strengths over 50%

(1)

Strengths of 50% and under

(2)

Its analogues, homologues, compounds, intermediates,

P.U. (A) 207 10

derivatives, esters, ethers, salts and other substances structurally derived”;

(xii)

dengan memasukkan selepas butiran “Dimethoxybromoamphetamine (DOB) (DD)” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“2,5-dimethoxy-α,4-

dimethylphenethylamine

(STP/DOM) (DD)

-

All preparations”;

(xiii)

dengan menggantikan butiran “Dinitronaphthols” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

P.U. (A) 207 11

Names

Exempt

Group A

Group B

Group C

Group D

“Dinitronaphthols

-

All preparations unless exempted

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xiv)

dengan menggantikan butiran “Dinitrophenols” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Dinitrophenols

-

All preparations unless exempted

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 12

(xv)

dengan menggantikan butiran “Dinitrothymols” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Dinitrothymols

-

All preparations unless exempted

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xvi)

dengan menggantikan butiran “Flunitrazepam; its salts (DD)” dengan butiran “Flunitrazepam (DD)”;

(xvii)

dengan memasukkan selepas butiran “Fluorides, alkali; organo fluorides” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“4-Fluoroamphetamine

(4-FA) (DD)

-

All preparations”;

P.U. (A) 207 13

(xviii)

dengan menggantikan butiran “Formaldehyde” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Formaldehyde

-

5% and over calculated as

(1)

Under 5% calculated as

(2)

Photographic glazing or hardening solution

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xix)

dengan menggantikan butiran “Hydrazines, benzyl, phenethyl, phenoxyethyl; their alpha-methyl derivatives;

acyl derivatives of any of the foregoing substances comprised in this item; salts of any compound comprised in this item” dengan butiran “Hydrazines, benzyl, phenethyl, phenoxyethyl; their alpha-methyl derivatives;

acyl derivatives of any of the foregoing substances comprised in this item; salts of any compound comprised in this item, for therapeutic use”;

P.U. (A) 207 14

(xx)

dengan menggantikan butiran “Hydrochloric acid” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Hydrochloric acid; hydrogen chloride

-

9% and over calculated as

HCl

(1)

Under 9% calculated as HCl

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxi)

dengan menggantikan butiran “Hydrogen bromide” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Hydrogen bromide;

-

All preparations

(1)

Preparations ready for use as pesticides

P.U. (A) 207 15

hydrobromic acid unless exempted

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxii)

dengan menggantikan butiran “Hydrofluoric acid” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Hydrofluoric acid;

hydrogen fluoride

-

All preparations unless exempted

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxiii)

dengan menggantikan butiran “Hydroquinone” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

P.U. (A) 207 16

Names

Exempt

Group A

Group B

Group C

Group D

“Hydroquinone

-

All medicinal preparations unless exempted

-

All preparations unless in Group C or exempted

(1)

Artificial nail systems which is a notified cosmetic under the

Control of Drugs and

Cosmetics Regulations 1984, containing hydroquinone not more than 0.02% w/w

(2)

Notified cosmetic under the Control of Drugs and

Cosmetics Regulations 1984 containing arbutin

(3)

Its analogues, homologues, compounds, intermediates,

P.U. (A) 207 17

derivatives, esters, ethers, salts and other substances structurally derived”;

(xxiv)

dengan menggantikan butiran “Isoniazid; its salts” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Isoniazid; its salts

-

All medicinal preparations

All preparations unless in

Group C”;

(xxv)

dengan menggantikan butiran “Local anaesthetics; the following: their salts; their homologues and analogues;

their molecular compounds:” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

P.U. (A) 207 18

Names

Group A

Group B

Group C

Group D

“Local anaesthetics; the following: their salts;

their homologues and analogues; their molecular compounds:

Amino-alcohols esterified with benzoic acid, phenylacetic acid, phenylpropionic acid, cinnamic acid or the derivatives of these acids; their salts

Benzocaine

Bupivacaine

Butyl aminobenzoate

Cinchocaine

All condoms or preparations containing local anaesthetics unless in

Group B,

Group C or

Group D

All preparations in pharmaceutical dosage forms unless in

Group C

(1)

All preparations in pharmaceutical dosage form for topical use in the nose, eyes and ears or external use

(2)

Suppositories, lozenges and pastilles

(3)

Preparations in the form of cartridges for dental use containing 2% or less of local anaesthetic

Preparations for laboratory use”;

P.U. (A) 207 19

Diperodon

Etidocaine

Lignocaine

Levobupivacaine

Mepivacaine

Orthocaine

Oxethazaine

Phenacaine

Phenodianisyl

Prilocaine

Ropivacaine

Tetracaine

(xxvi)

dengan menggantikan butiran

“Mercury”

dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Mercury

-

All preparations unless

-

(1)

Cosmetic which is notified under the Control of Drugs and

Cosmetics Regulations 1984

P.U. (A) 207 20

exempted containing not more than 1 part per million of mercury calculated as the metal

(2)

Product which is registered under the Control of Drugs and

Cosmetics Regulations 1984

containing not more than 0.5 part per million of mercury calculated as the metal

(3)

Appliances containing mercury”;

(xxvii)

dengan memasukkan selepas butiran “Methyl bromide” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Methyl (2S)-2-{[1-(5-fluoropentyl)-

1H-indazole-3-carbonyl]amino}-3,3-

dimethylbutanoate

(5F-ADB/5F-MDMB-PINACA) (DD)

-

All preparations”;

P.U. (A) 207 21

(xxviii)

dengan memasukkan selepas butiran “Miconazole; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Midostaurin

-

All preparations”;

(xxix)

dalam butiran “Narcotic substances, the following: their isomers (whenever the existence of such isomers is possible within the specific chemical designation); their salts; their esters and ethers (whenever the existence of such esters or ethers is possible); the salts of their esters and ethers-”—

(A)

dengan memasukkan selepas butiran “(DD) Acetylmethadol” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Acryloylfentanyl

-

All preparations”;

P.U. (A) 207 22

(B)

dengan memasukkan selepas butiran “(DD) Betameprodine” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Betamethadol

-

All preparations”;

(C)

dengan memasukkan selepas butiran “(DD) Cannabis, its resin, extracts and tinctures of; cannabin tannate”

dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Carfentanil

-

All preparations”;

(D)

dengan memasukkan selepas butiran “(DD) Fentanyl” dan butir-butir yang berhubungan dengannya butiran yang berikut:

P.U. (A) 207 23

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) 4-Fluoroisubutyrfentanyl

(4-FIBF, pFIBF)

-

All preparations

(DD)

Furanyl fentanyl

-

All preparations”;

(E)

dengan memasukkan selepas butiran “(DD) Norpipanone” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Ocfentanil

-

All preparations”;

(F)

dengan menggantikan butiran “(DD) Racemethorplan” dengan butiran “(DD) Racemethorphan”;

(G)

dengan memasukkan selepas butiran “(DD) Sufentanil” dan butir-butir yang berhubungan dengannya butiran yang berikut:

P.U. (A) 207 24

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Tetrahydrofuranyl fentanyl (THF-F)

-

All preparations”;

(xxx)

dengan menggantikan butiran “Nimetazepam; its salts (DD)” dengan butiran “Nimetazepam (DD)”;

(xxxi)

dengan menggantikan butiran

“Nitric acid”

dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Nitric acid

-

9% w/w and over

(1)

Under 9% w/w

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 25

(xxxii)

dengan memasukkan selepas butiran “Pentoxifylline” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“(1-Pentyl-1H-indol-3-yl)(2,2,3,3-

tetramethylcyclopropyl)methanone

(UR-144) (DD)

-

All preparations”;

(xxxiii)

dengan menggantikan butiran “Phenols (any member of the series of phenols of which the first member is phenol)

and of which the molecular composition varies from member to member by one atom of carbon and two atoms of hydrogen); compounds of phenol with a metal” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Phenols (any member of the series of phenols of which the first member is phenol and

-

All preparations for diagnostic or therapeutic

-

All preparations other than those in Part I

(1)

Paratertiary amyl phenol;

tertiary butyl cresol;

thymol; carvacrol; soap; tar

(coal or wood); essential

P.U. (A) 207 26

of which the molecular composition varies from member to member by one atom of carbon and two atoms of hydrogen);

compounds of phenol with a metal use unless exempted or exempted oils; essential oils in which phenols occur naturally

(2)

Strengths under 2.5% w/w of phenols

(3)

5% w/w of phenols or under in surgical dressings for human or animal use

(4)

Its analogues, homologues, compounds (other than compounds of phenol with a metal), intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxxiv)

dengan menggantikan butiran “Phosphorus” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

P.U. (A) 207 27

Names

Exempt

Group A

Group B

Group C

Group D

“Phosphorus white, yellow, red or black

-

All preparations unless exempted

(1)

Phosphorus in food, notified cosmetic or registered product under the Control of Drugs and

Cosmetics Regulations 1984

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxxv)

dengan menggantikan butiran “Potassium hydroxide” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Potassium hydroxide

-

12% and over unless

(1)

Under 12%

(2)

Accumulators, batteries or when use as

P.U. (A) 207 28

exempted food additive in food

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxxvi)

dengan menggantikan butiran “Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22)” dengan butiran “Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22) (DD)”;

(xxxvii)

dengan menggantikan butiran “Safrole” dengan butiran “Safrole; includes safrole-rich oil”;

(xxxviii)

xxxviii

dengan memasukkan selepas butiran “Selenium sulphide” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Selexipag

-

All preparations”;

(xxxix)

dengan menggantikan butiran “Sodium hydroxide” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

P.U. (A) 207 29

Names

Exempt

Group A

Group B

Group C

Group D

“Sodium hydroxide

-

All preparations for therapeutic or diagnostic use

-

All preparations containing 12% and over other than those in Part I or exempted and subject to the provisions of

Poisons (Sodium

Hydroxide)

Regulations, 1962

(1)

Under 12%

(2)

Sodium hydroxide when use as food additive in food

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xl)

dengan menggantikan butiran “Sulphuric acid” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

P.U. (A) 207 30

Names

Exempt

Group A

Group B

Group C

Group D

“Sulphuric acid

-

9% w/w and over unless exempted

(1)

Under 9% w/w

(2)

Accumulators; batteries; fire-extinguishers

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xli)

dengan menggantikan butiran “Thallium; salts of” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Thallium;

salts of

-

All medicinal preparations

-

All preparations unless in Group B”;

P.U. (A) 207 31

(xlii)

dengan menggantikan butiran “Thionyl Chloride” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Thionyl Chloride

-

All preparations unless exempted

-

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xliii)

dengan menggantikan butiran “Thiouracil and other substances structurally derived therefrom” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Thiouracil and other substances structurally derived therefrom

-

All medicinal preparations

-

All preparations unless in Group B”;

P.U. (A) 207 32

(xliv)

dengan menggantikan butiran “L-Tryptophan” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“L-Tryptophan

-

All preparations unless exempted

-

(1)

Preparations containing naturally occurring L-Tryptophan

(2)

Animal feed or feed additive

(3)

Food and its added nutrient”;

(xlv)

dengan menggantikan butiran “Urea” dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Group A

Group B

Group C

Group D

“Urea in medicinal preparation containing 40% and above of urea

-

All medicinal preparations”;

P.U. (A) 207 33

(xlvi)

dengan menggantikan butiran

“13C-Urea”

dan butir-butir yang berhubungan dengannya dengan butiran yang berikut:

Names

Group A

Group B

Group C

Group D

“13C-Urea in medicinal preparations

-

All medicinal preparations”; dan

(xlvii)

dengan memasukkan selepas butiran “Vismodegib” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Group A

Group B

Group C

Group D

“Vonoprazan

-

All preparations”; dan

(b)

dalam Lampiran kepada Senarai Racun—

(i)

dalam senarai “Analeptics and Central Stimulants”—

(A)

dengan memasukkan sebelum butiran “Amiphenazole; its salts” butiran “N-[(2S)-1-Amino-3-methyl-1-

oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) (DD)”;

P.U. (A) 207 34

(B)

dengan memasukkan selepas butiran “Fenetylline” butiran “Fluoroamphetamine (4-FA) (DD)”;

dengan memasukkan selepas butiran “Methylphenidate; its salts” butiran “Methyl (2S)-2-{[1-(5-

fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-ADB/5F-MDMB-PINACA) (DD)”;

dan

(D)

dengan memasukkan selepas butiran “Pemoline; its salts” butiran “(1-Pentyl-1H-indol-3-yl)(2,2,3,3-

tetramethylcyclopropyl)methanone (UR-144) (DD)”;

(ii)

dalam senarai “Analgesics including antipyretic and anti-inflammatory agents”—

(A)

dengan menggantikan butiran “N- [(1S) - 1-

(Aminocarbonyl) - 2- methylpropyl] - 1-

(cyclohexylmethyl) 1H-indazole- 3- carboxamide (AB-CHMINACA)” dengan butiran “N-[(2S)-1-Amino-3-methyl-1-oxobutan-2yl]-1-

(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) (DD)”; dan

(B)

dengan menggantikan butiran “Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- carboxylate (5F-PB-22)”

dengan butiran “Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22) (DD)”;

(iii)

dalam senarai “Antidepressants”, dengan menggantikan butiran “Hydrazines, benzyl, phenethyl, phenoxyethyl;

their alpha-methyl derivatives; acyl derivatives of any of the foregoing substances comprised in this item; salts of any compound comprised in this item” dengan butiran “Hydrazines, benzyl, phenethyl, phenoxyethyl; their

P.U. (A) 207 35

alpha-methyl derivatives; acyl derivatives of any of the foregoing substances comprised in this item; salts of any compound comprised in this item for therapeutic use”;

(iv)

dalam senarai “Antifungals and Antiprotozoals”, dengan menggantikan butiran “Urea” dengan butiran

“Urea in medicinal preparation containing 40% and above of urea”;

(v)

dalam senarai

“Antihypertensives”, dengan menggantikan butiran

“Oxyclonazide”

dengan butiran

“Oxyclozanide”;

(vi)

dalam senarai “Antineoplastic agents and Immunosuppressants”—

(A)

dengan memasukkan selepas butiran “Anastrozole” butiran “Apremilast”;

(B)

dengan memasukkan selepas butiran “Methotrexate; its salts” butiran “Midostaurin”; dan

(C)

dengan memasukkan selepas butiran “Trofosfamide” butiran “Vedolizumab”;

(vii)

dalam senarai “Anti-ulcer agents”, dengan memasukkan selepas butiran “Roxatidine” butiran “Vonoprazan”;

(viii)

dalam senarai “Industrial and laboratory poisons”—

P.U. (A) 207 36

(A)

dengan menggantikan butiran “Hydrochloric acid” dengan butiran “Hydrochloric acid; hydrogen chloride”;

dan

(B)

dengan menggantikan butiran “Safrole” dengan butiran “Safrole; includes safrole-rich oil”;

(ix)

dalam senarai “Narcotics”—

(A)

dengan memasukkan selepas butiran “(DD) Acetylmethadol” butiran “(DD) Acryloylfentanyl”;

(B)

dengan memasukkan selepas butiran “(DD) Cannabis, its resin, extracts and tinctures of; cannabin tannate”

butiran “(DD) Carfentanil”;

(C)

dengan memasukkan selepas butiran “(DD) Fentanyl” butiran yang berikut:

“(DD) 4-Fluoroisubutyrfentanyl (4-FIBF, pFIBF)

(DD)

Furanyl fentanyl”;

(D)

dengan memasukkan selepas butiran “(DD) Norpipanone” butiran “(DD) Ocfentanil”;

(E)

dengan memasukkan selepas butiran “(DD) Racemorphan” butiran “(DD) Remifentanil”; dan

P.U. (A) 207 37

(F)

dengan memasukkan selepas butiran “(DD) Sufentanil” butiran “(DD) Tetrahydrofuranyl fentanyl (THF-F)”;

(x)

dalam senarai “Tranquillisers”—

(A)

dengan memasukkan selepas butiran “Diazepam and other substances structurally derived from 1,

4-benzodiazepine; their salts, unless specified elsewhere in the List” butiran “1-(2,5-Dimethoxy-4-

methylphenyl)propan-2-amine (STP/DOM) (DD)”;

(B)

dengan menggantikan butiran “Flunitrazepam; its salts” dengan butiran “Flunitrazepam (DD)”;

(C)

dengan menggantikan butiran “Nimetazepam; its salts” dengan butiran “Nimetazepam (DD)”; dan

(D)

dengan menggantikan butiran “Zolzepam” dengan butiran “Zolazepam”; dan

(xi)

dalam senarai “Miscellaneous”—

(A)

dengan memotong butiran “Carfentanil citrate”;

(B)

dengan memotong butiran “Furazolidone”;

P.U. (A) 207 38

(C)

dengan menggantikan butiran “Phosphorus” dengan butiran “Phosphorus white, yellow, red or black”;

(D)

dengan memasukkan selepas butiran “Selenium sulphide” butiran “Selexipag”; dan

(E)

dengan menggantikan butiran “13-C Urea” dengan butiran “13C-Urea in medicinal preparations”.

Dibuat 25 Jun 2019

[KKM.R.600-1/1/56 JLD.4(8); PN(PU2)172/XVII]

DATUK SERI DR. DZULKEFLY BIN AHMAD

Menteri Kesihatan

P.U. (A) 207 39

POISONS ACT 1952

POISONS (AMENDMENT OF POISONS LIST) (NO. 3) ORDER 2019

Seksyen 1

This order may be cited as the Poisons (Amendment of Poisons List) (No. 3) Order 2019.

Seksyen 2

Amendment of First Schedule

The Poisons Act 1952 is amended in the First Schedule—

(a)

in the Poisons List—

(i)

by substituting for the item “Adenosine” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Adenosine

-

Medicinal preparations unless exempted

All preparations unless in Group C

-

Adenosine in—

(1)

raw cordyceps

P.U. (A) 207 40

or exempted

(2)

product which is registered under the

Control of Drugs and

Cosmetics

Regulations 1984

containing adenosine from natural resources

(3)

cosmetic which is notified under the

Control of Drugs and

Cosmetics

Regulations 1984

(4)

food”;

(ii)

by substituting for the item “N- [(1S) - 1-

(Aminocarbonyl) - 2- methylpropyl] - 1-

(cyclohexylmethyl) 1H-indazole-carboxamide

(AB-CHMINACA)”

the item

“N-[(2S)-1-Amino-3-methyl-1-oxobutan-2yl]-1-

(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) (DD)”;

P.U. (A) 207 41

(iii)

by inserting after the item “2-Amino-1-(2, 5-dimethoxy-4- methyl) phenylpropane (DD)” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“N-[(2S)-1-Amino-3-methyl-1-

oxobutan-2-yl]-1-pentyl- 1H-indazole-3-carboxamide

(AB-PINACA) (DD)

-

All preparations”;

(iv)

by substituting for the item “Ammonia” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Ammonia

-

5% and above (1) Below 5%

(2)

Ammonia inside cooling units of a refrigerator, air conditioner and smelling bottles

(3)

Its analogues, homologues,

P.U. (A) 207 42

compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(v)

by inserting after the item “Apraclonidine; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Apremilast

-

All preparations”;

(vi)

by substituting for the item “Azelaic Acid” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Azelaic Acid

-

All medicinal preparations unless in Group C

Medicinal preparations for external use

All preparations unless in

Group B or

Group C”;

P.U. (A) 207 43

(vii)

by substituting for the item “Bismuth; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Bismuth; its salts

-

All medicinal preparations unless in

Group C or exempted

Suppositories and medicinal preparations for external use unless exempted

All preparations unless in

Group B,

Group C or exempted

-

Cosmetics including those for the eye, containing bismuth oxychloride as a pearling or colouring agent”;

(viii)

by substituting for the item “Caffeine” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Caffeine

-

All preparations unless exempted

(1)

Caffeine in—

(i)

food or beverages

(ii)

cosmetic which is notified under the

Control of Drugs and Cosmetics

P.U. (A) 207 44

Regulations 1984

(iii)

product which is registered under the

Control of Drugs and Cosmetics

Regulations 1984

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(ix)

by deleting the item “Carfentanil citrate” and the particulars relating to it;

(x)

by substituting for the item “Chloroform” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Chloroform

Veterinary preparations for food-producing animals

-

Medicinal preparation unless in Group A or exempted

All preparation unless in Group A,

Group C or exempted

-

Strengths under 10% unless

Group A”;

P.U. (A) 207 45

(xi)

by substituting for the item “Creosote, obtained from wood” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Creosote, obtained from wood

-

Strengths over 50%

(1)

Strengths of 50% and under

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xii)

by inserting after the item “Dimethoxybromoamphetamine (DOB) (DD)” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“2,5-dimethoxy-α,4-

dimethylphenethylamine

(STP/DOM) (DD)

-

All preparations”;

P.U. (A) 207 46

(xiii)

by substituting for the item “Dinitronaphthols” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Dinitronaphthols

-

All preparations unless exempted

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xiv)

by substituting for the item “Dinitrophenols” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Dinitrophenols

-

All preparations unless exempted

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 47

(xv)

by substituting for the item “Dinitrothymols” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Dinitrothymols

-

All preparations unless exempted

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xvi)

by substituting for the item “Flunitrazepam, its salts (DD)” the item “Flunitrazepam (DD)”;

(xvii)

by inserting after the item “Fluorides, alkali; organo fluorides” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“4-Fluoroamphetamine

(4-FA) (DD)

-

All preparations”;

P.U. (A) 207 48

(xviii)

by substituting for the item “Formaldehyde” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Formaldehyde

-

5% and over calculated as

(1)

Under 5% calculated as HCHO

(2)

Photographic glazing or hardening solution

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xix)

by substituting for the item “Hydrazines, benzyl, phenethyl, phenoxyethyl; their alpha-methyl derivatives;

acyl derivatives of any of the foregoing substances comprised in this item; salts of any compound comprised in this item” the item “Hydrazines, benzyl, phenethyl, phenoxyethyl; their alpha-methyl derivatives; acyl derivatives of any of the foregoing substances comprised in this item; salts of any compound comprised in this item, for therapeutic use”;

(xx)

by substituting for the item “Hydrochloric acid” and the particulars relating to it the following item:

P.U. (A) 207 49

Names

Exempt

Group A

Group B

Group C

Group D

“Hydrochloric acid;

hydrogen chloride

-

9% and over calculated as

HCl

(1)

Under 9% calculated as HCl

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxi)

by substituting for the item “Hydrogen bromide” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Hydrogen bromide;

hydrobromic acid

-

All preparations unless exempted

(1)

Preparations ready for use as pesticides

(2)

Its analogues, homologues, compounds, intermediates,

P.U. (A) 207 50

derivatives, esters, ethers, salts and other substances structurally derived”;

(xxii)

by substituting for the item “Hydrofluoric acid” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Hydrofluoric acid;

hydrogen fluoride

-

All preparations unless exempted

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxiii)

by substituting for the item “Hydroquinone” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Hydroquinone

-

All medicinal preparations

-

All preparations

(1)

Artificial nail systems which is a notified cosmetic under the

P.U. (A) 207 51

unless exempted unless in

Group C or exempted

Control of Drugs and

Cosmetics Regulations 1984, containing hydroquinone not more than 0.02% w/w

(2)

Notified cosmetic under the

Control of Drugs and

Cosmetics Regulations 1984

containing arbutin

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxiv)

by substituting for the item “Isoniazid; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Isoniazid; its salts

-

All medicinal preparations

All preparations unless in Group C”;

P.U. (A) 207 52

(xxv)

by substituting for the item “Local anaesthetics; the following: their salts; their homologues and analogues; their molecular compounds:” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Local anaesthetics; the following: their salts;

their homologues and analogues; their molecular compounds:

Amino-alcohols esterified with benzoic acid, phenylacetic acid, phenylpropionic acid, cinnamic acid or the derivatives of these acids;

their salts

Benzocaine

Bupivacaine

Butyl aminobenzoate

All condoms or preparations containing local anaesthetics unless in

Group B,

Group C or

Group D

All preparations in pharmaceutical dosage forms unless in

Group C

(1)

All preparations in pharmaceutical dosage form for topical use in the nose, eyes and ears or external use

(2)

Suppositories, lozenges and pastilles

(3)

Preparations in the form of cartridges for dental use containing 2% or less of local anaesthetic

Preparations for laboratory use”;

P.U. (A) 207 53

Cinchocaine

Diperodon

Etidocaine

Lignocaine

Levobupivacaine

Mepivacaine

Orthocaine

Oxethazaine

Phenacaine

Phenodianisyl

Prilocaine

Ropivacaine

Tetracaine

(xxvi)

by substituting for the item “Mercury” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Mercury

-

All preparations unless exempted

-

(1)

Cosmetic which is notified under the Control of Drugs and

Cosmetics Regulations 1984

P.U. (A) 207 54

containing not more than 1

part per million of mercury calculated as the metal

(2)

Product which is registered under the Control of Drugs and

Cosmetics Regulations 1984

containing not more than 0.5

part per million of mercury calculated as the metal

(3)

Appliances containing mercury”;

(xxvii)

by inserting after the item “Methyl bromide” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-

dimethylbutanoate

(5F-ADB/5F-MDMB-PINACA) (DD)

-

All preparations”;

P.U. (A) 207 55

(xxviii)

by inserting after the item “Miconazole; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Midostaurin

-

All preparations”;

(xxix)

in the item “Narcotic substances, the following: their isomers (whenever the existence of such isomers is possible within the specific chemical designation); their salts; their esters and ethers (whenever the existence of such esters or ethers is possible); the salts of their esters and ethers-”—

(A)

by inserting after the item “(DD) Acetylmethadol” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Acryloylfentanyl

-

All preparations”;

(B)

by inserting after the item “(DD) Betameprodine” and the particulars relating to it the following item:

P.U. (A) 207 56

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Betamethadol

-

All preparations”;

by inserting after the item “(DD) Cannabis, its resin, extracts and tinctures of; cannabin tannate” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Carfentanil

-

All preparations”;

P.U. (A) 207 57

(D)

by inserting after the item “(DD) Fentanyl” and the particulars relating to it the following items:

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) 4-Fluoroisubutyrfentanyl

(4-FIBF, pFIBF)

-

All preparations

(DD)

Furanyl fentanyl

-

All preparations”;

(E)

by inserting after the item “(DD) Norpipanone” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Ocfentanil

-

All preparations”;

(F)

by substituting for the item “(DD) Racemethorplan” the item “(DD) Racemethorphan”;

(G)

by inserting after the item “(DD) Sufentanil” and the particulars relating to it the following item:

P.U. (A) 207 58

Names

Exempt

Group A

Group B

Group C

Group D

“(DD) Tetrahydrofuranyl fentanyl (THF-F)

-

All preparations”;

(xxx)

by substituting for the item “Nimetazepam; its salts (DD)” the item “Nimetazepam (DD)”;

(xxxi)

by substituting for the item “Nitric acid” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Nitric acid

-

9% w/w and over

(1)

Under 9% w/w

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 59

(xxxii)

by inserting after the item “Pentoxifylline” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“(1-Pentyl-1H-indol-3-yl)

(2,2,3,3-tetramethylcyclopropyl)

methanone (UR-144)(DD)

-

All preparations”;

(xxxiii)

by substituting for the item “Phenols (any member of the series of phenols of which the first member is phenol)

and of which the molecular composition varies from member to member by one atom of carbon and two atoms of hydrogen); compounds of phenol with a metal” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Phenols (any member of the series of phenols of which the first member is phenol and of which the molecular

-

All preparations for diagnostic or therapeutic use unless exempted

-

All preparations other than those in Part I or exempted

(1)

Paratertiary amyl phenol; tertiary butyl cresol; thymol;

carvacrol; soap; tar

(coal or wood)

P.U. (A) 207 60

composition varies from member to member by one atom of carbon and two atoms of hydrogen);

compounds of phenol with a metal essential oils; essential oils in which phenols occur naturally

(2)

Strengths under 2.5%

w/w of phenols

(3)

5% w/w of phenols or under in surgical dressings for human or animal use

(4)

Its analogues, homologues, compounds (other than compounds of phenol with a metal), intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 61

(xxxiv)

by substituting for the item “Phosphorus” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Phosphorus white, yellow, red or black

-

All preparations unless exempted

(1)

Phosphorus in food, notified cosmetic or registered product under the Control of Drugs and

Cosmetics Regulations 1984

(2)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxxv)

by substituting for the item “Potassium hydroxide” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Potassium hydroxide

-

12% and over unless exempted

(1)

Under 12%

(2)

Accumulators, batteries or

P.U. (A) 207 62

when use as food additive in food

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

(xxxvi)

by substituting for the item “Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22)” the item

“Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22) (DD)”;

(xxxvii)

by substituting for the item “Safrole” the item “Safrole; includes safrole-rich oil”;

(xxxviii)

xxxviii

by inserting after the item “Selenium sulphide” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Selexipag

-

All preparations”;

P.U. (A) 207 63

(xxxix)

by substituting for the item “Sodium hydroxide” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Sodium hydroxide

-

All preparations for therapeutic or diagnostic use

-

All preparations containing 12%

and over other than those in

Part I or exempted and subject to the provisions of

Poisons (Sodium

Hydroxide)

Regulations, 1962

(1)

Under 12%

(2)

Sodium hydroxide when use as food additive in food

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 64

(xl)

by substituting for the item “Sulphuric acid” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Sulphuric acid

-

9% w/w and over unless exempted

(1)

Under 9% w/w

(2)

Accumulators; batteries;

fire-extinguishers

(3)

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 65

(xli)

by substituting for the item “Thallium; salts of” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Thallium; salts of

-

All medicinal preparations

-

All preparations unless in Group B”;

(xlii)

by substituting for the item “Thionyl Chloride” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Thionyl Chloride

-

All preparations unless exempted

-

Its analogues, homologues, compounds, intermediates, derivatives, esters, ethers, salts and other substances structurally derived”;

P.U. (A) 207 66

(xliii)

by substituting for the item “Thiouracil and other substances structurally derived therefrom” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Thiouracil and other substances structurally derived therefrom

-

All medicinal preparations

-

All preparations unless in

Group B”;

(xliv)

by substituting for the item “L-Tryptophan” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“L-Tryptophan

-

All preparations unless exempted

-

(1)

Preparations containing naturally occurring L-Tryptophan

(2)

Animal feed or feed additive

(3)

Food and its added nutrient”;

P.U. (A) 207 67

(xlv)

by substituting for the item “Urea” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Urea in medicinal preparation containing 40%

and above of urea

-

All medicinal preparations”;

(xlvi)

by substituting for the item “13C-Urea” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“13C-Urea in medicinal preparations

-

All medicinal preparations”; and

P.U. (A) 207 68

(xlvii)

by inserting after the item “Vismodegib” and the particulars relating to it the following item:

Names

Group A

Group B

Group C

Group D

“Vonoprazan

-

All preparations”; and

(b)

in the Appendix to the Poisons List—

(i)

in the list of “Analeptics and Central Stimulants”—

(A)

by inserting before the item “Amiphenazole; its salts” the item “N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-

1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) (DD)”;

(B)

by inserting after the item“Fenetylline” the item “Fluoroamphetamine (4-FA) (DD)”;

by inserting after the item “Methylphenidate; its salts” the item “Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-ADB/5F-MDMB-PINACA) (DD)”; and

(D)

by inserting after the item

“Pemoline;

its salts”

the item

“(1-Pentyl-1H-indol-3-yl)(2,2,3,3-

tetramethylcyclopropyl)methanone (UR-144) (DD)”;

P.U. (A) 207 69

(ii)

in the list of “Analgesics including antipyretic and anti-inflammatory agents”—

(A)

by substituting for the item “N- [(1S) - 1-

(Aminocarbonyl) - 2- methylpropyl] - 1-

(cyclohexylmethyl) 1H-indazole- 3- carboxamide (AB-CHMINACA)” the item “N-[(2S)-1-Amino-3-methyl-1-oxobutan-2yl]-1-

(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) (DD)”; and

(B)

by substituting for the item “Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- carboxylate (5F-PB-22)” the item

“Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22) (DD)”;

(iii)

in the list of “Antidepressants”, by substituting for the item “Hydrazines, benzyl, phenethyl, phenoxyethyl; their alpha-methyl derivatives; acyl derivatives of any of the foregoing substances comprised in this item; salts of any compound comprised in this item” the item “Hydrazines, benzyl, phenethyl, phenoxyethyl; their alpha-methyl derivatives; acyl derivatives of any of the foregoing substances comprised in this item; salts of any compound comprised in this item for therapeutic use”;

(iv)

in the list of “Antifungals and Antiprotozoals”, by substituting for the item “Urea” the item “Urea in medicinal preparation containing 40% and above of urea”;

(v)

in the list of “Antihypertensives”, by substituting for the item “Oxyclonazide” the item “Oxyclozanide”;

P.U. (A) 207 70

(vi)

in the list of “Antineoplastic agents and Immunosuppressants”—

(A)

by inserting after the item “Anastrozole” the item “Apremilast”;

(B)

by inserting after the item “Methotrexate; its salts ” the item “Midostaurin”; and

(C)

by inserting after the item “Trofosfamide” the item “Vedolizumab”;

(vii)

in the list of “Anti-ulcer agents”, by inserting after the item “Roxatidine” the item “Vonoprazan”;

(viii)

in the list of “Industrial and laboratory poisons”—

(A)

by substituting for the item “Hydrochloric acid” the item “Hydrochloric acid; hydrogen chloride”; and

(B)

by substituting for the item “Safrole” the item “Safrole; includes safrole-rich oil”;

(ix)

in the list of “Narcotics”—

(A)

by inserting after the item “(DD) Acetylmethadol” the item “(DD) Acryloylfentanyl”;

(B)

by inserting after the item “(DD) Cannabis, its resin, extracts and tinctures of; cannabin tannate” the item

“(DD) Carfentanil”;

P.U. (A) 207 71

(C)

by inserting after the item “(DD) Fentanyl” the following items:

“(DD) 4-Fluoroisubutyrfentanyl (4-FIBF, pFIBF)

(DD)

Furanyl fentanyl”;

(D)

by inserting after the item “(DD) Norpipanone” the item “(DD) Ocfentanil”;

(E)

by inserting after the item “(DD) Racemorphan” the item “(DD) Remifentanil”; and

(F)

by inserting after the item “(DD) Sufentanil” the item “(DD) Tetrahydrofuranyl fentanyl (THF-F)”;

(x)

in the list of “Tranquillisers”—

(A)

by inserting after the item “Diazepam and other substances structurally derived from 1, 4-benzodiazepine;

their salts, unless specified elsewhere in the List” the item “1-(2,5-Dimethoxy-4-methylphenyl)propan-2-

amine (STP/DOM) (DD)”;

(B)

by substituting for the item “Flunitrazepam; its salts” the item “Flunitrazepam (DD)”;

(C)

by substituting for the item “Nimetazepam; its salts” the item “Nimetazepam (DD)”; and

P.U. (A) 207 72

(D)

by substituting for the item “Zolzepam” the item “Zolazepam”; and

(xi)

in the list of “Miscellaneous”—

(A)

by deleting the item “Carfentanil citrate”;

(B)

by deleting the item “Furazolidone”;

(C)

by substituting for the item “Phosphorus” the item “Phosphorus white, yellow, red or black”;

(D)

by inserting after the item “Selenium sulphide” the item “Selexipag”; and

(E)

by substituting for the item “13-C Urea” the item “13C-Urea in medicinal preparations”.

Made 25 June 2019

[KKM.R.600-1/1/56 JLD.4(8); PN(PU2)172/XVII]

DATUK SERI DR. DZULKEFLY BIN AHMAD

Minister of Health

PERINTAH RACUN (PINDAAN SENARAI RACUN) (NO. 3) 2019

About this p.u. (a)

(a)

(i)

Part I

Part II

(1)

(2)

(3)

(4)

(ii)

(iii)

(iv)

(1)

(2)

(3)

(v)

(vi)

(vii)

(viii)

(1)

(i)

(ii)

(iii)

(2)

(ix)

(x)

(xi)

(1)

(2)

(xii)

(xiii)

(xiv)

(xv)

(xvi)

(xvii)

(xviii)

(1)

(2)

(3)

(xix)

(xx)

(1)

(2)

(xxi)

(1)

(2)

(xxii)

(xxiii)

(1)

(2)

(3)

(xxiv)

(xxv)

Part II Exempt

(1)

(2)

(3)

(xxvi)

(1)

(2)

(3)

(xxvii)

(xxviii)

(xxix)

(A)

(B)

(C)

(D)

(DD)

(E)

(F)

(G)

(xxx)

(xxxi)

(1)

(2)

(xxxii)

(xxxiii)

(1)